During the past decade, New Mazloum Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New Mazloum Hospital" are "Cervical Osteoarthritis" (1 trials), "Postoperative Pain" (1 trials) and "Total Knee Arthroplasty" (1 trials). Many other conditions were trialed in "New Mazloum Hospital" in a lesser frequency.

Most popular intervention types in "New Mazloum Hospital" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ActiPatch" (1 trials), "Etoricoxib 60 mg" (1 trials), "RecoveryRx" (1 trials), "Sham RecoveryRx" (1 trials) and "pulsed shortwave therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Mazloum Hospital" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New Mazloum Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New Mazloum Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New Mazloum Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".